Meissner Wassilios - Related publications

CHU Bordeaux, Pessac, Nouvelle-Aquitaine, France 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Ma YF, Lin YA, Huang CL, Hsu CC, Wang S, Yeh SR, Tsai YC. Lactiplantibacillus plantarum PS128 Alleviates Exaggerated Cortical Beta Oscillations and Motor Deficits in the 6-Hydroxydopamine Rat Model of Parkinson's Disease. Probiotics and Antimicrobial Proteins. PMID 34449056 DOI: 10.1007/s12602-021-09828-x   
2021 Lazcano-Ocampo C, van Wamelen D, Samuel M, Silverdale M, Rizos A, Sauerbier A, Koch J, Podlewska A, Leta V, Dafsari HS, Timmermann L, Ashkan K, Ray Chaudhuri K. Evaluation of the effect of bilateral subthalamic nucleus deep brain stimulation on fatigue in Parkinson's Disease as measured by the non-motor symptoms scale. British Journal of Neurosurgery. 1-4. PMID 34357840 DOI: 10.1080/02688697.2021.1961681   
2021 Van Laar AD, Van Laar VS, San Sebastian W, Merola A, Bradley Elder J, Lonser RR, Bankiewicz KS. An Update on Gene Therapy Approaches for Parkinson's Disease: Restoration of Dopaminergic Function. Journal of Parkinson's Disease. PMID 34366374 DOI: 10.3233/JPD-212724   
2021 Jiang L, Chen W, Guo Q, Yang C, Gu J, Xian W, Liu Y, Zheng Y, Ye J, Xu S, Hu Y, Wu L, Chen J, Qian H, Fu X, et al. Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity. Cns Neuroscience & Therapeutics. PMID 34350691 DOI: 10.1111/cns.13713   
2021 Lin Z, Zhang C, Li D, Sun B. Lateralized effects of deep brain stimulation in Parkinson's disease: evidence and controversies. Npj Parkinson's Disease. 7: 64. PMID 34294724 DOI: 10.1038/s41531-021-00209-3   
2021 Metta V, Batzu L, Leta V, Trivedi D, Powdleska A, Mridula KR, Kukle P, Goyal V, Borgohain R, Chung-Faye G, Chaudhuri KR. Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors. Journal of Personalized Medicine. 11. PMID 34357147 DOI: 10.3390/jpm11070680   
2021 Bastioli G, Regoni M, Cazzaniga F, De Luca CMG, Bistaffa E, Zanetti L, Moda F, Valtorta F, Sassone J. Animal Models of Autosomal Recessive Parkinsonism. Biomedicines. 9. PMID 34356877 DOI: 10.3390/biomedicines9070812   
2021 Holanda VAD, Didonet JJ, Costa MBB, do Nascimento Rangel AH, da Silva ED, Gavioli EC. Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease. Pharmaceuticals (Basel, Switzerland). 14. PMID 34451872 DOI: 10.3390/ph14080775   
2021 Yao L, Wu J, Koc S, Lu G. Genetic Imaging of Neuroinflammation in Parkinson's Disease: Recent Advancements. Frontiers in Cell and Developmental Biology. 9: 655819. PMID 34336822 DOI: 10.3389/fcell.2021.655819   
2021 Pagonabarraga J, Tinazzi M, Caccia C, Jost WH. The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 90: 178-183. PMID 34275546 DOI: 10.1016/j.jocn.2021.05.056   
2021 Mottaghi S, Kohl S, Biemann D, Liebana S, Montaño Crespo RE, Buchholz O, Wilson M, Klaus C, Uchenik M, Münkel C, Schmidt R, Hofmann UG. Bilateral Intracranial Beta Activity During Forced and Spontaneous Movements in a 6-OHDA Hemi-PD Rat Model. Frontiers in Neuroscience. 15: 700672. PMID 34456673 DOI: 10.3389/fnins.2021.700672   
2021 Monge-Fuentes V, Biolchi Mayer A, Lima MR, Geraldes LR, Zanotto LN, Moreira KG, Martins OP, Piva HL, Felipe MSS, Amaral AC, Bocca AL, Tedesco AC, Mortari MR. Dopamine-loaded nanoparticle systems circumvent the blood-brain barrier restoring motor function in mouse model for Parkinson's Disease. Scientific Reports. 11: 15185. PMID 34312413 DOI: 10.1038/s41598-021-94175-8   
2021 Monge-Fuentes V, Biolchi Mayer A, Lima MR, Geraldes LR, Zanotto LN, Moreira KG, Martins OP, Piva HL, Felipe MSS, Amaral AC, Bocca AL, Tedesco AC, Mortari MR. Dopamine-loaded nanoparticle systems circumvent the blood-brain barrier restoring motor function in mouse model for Parkinson's Disease. Scientific Reports. 11: 15185. PMID 34312413 DOI: 10.1038/s41598-021-94175-8   
2021 Silva S, Almeida AJ, Vale N. Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs. Pharmaceutics. 13. PMID 33917696 DOI: 10.3390/pharmaceutics13040508   
2021 Wang Y, Gao P, Zhang X, Lv B, Xu Z, Cheng H. Bilateral subthalamic nucleus deep brain stimulation improves gastric emptying time in Parkinson's Disease. World Neurosurgery. PMID 34343688 DOI: 10.1016/j.wneu.2021.07.112   
2021 Maple-Grødem J, Paul KC, Dalen I, Ngo KJ, Wong D, Macleod AD, Counsell CE, Bäckström D, Forsgren L, Tysnes OB, Kusters CDJ, Fogel BL, Bronstein JM, Ritz B, Alves G. Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson's Disease Cohorts. Journal of Parkinson's Disease. PMID 34275908 DOI: 10.3233/JPD-212657   
2021 Taghizadeh E, Gheibihayat SM, Taheri F, Afshani SM, Farahani N, Saberi A. LncRNAs as putative biomarkers and therapeutic targets for Parkinson's disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 34254198 DOI: 10.1007/s10072-021-05408-7   
2021 Li Z, Ren G, Liu C, Wang Q, Liang K, Han C, Qiao H, Zhang J, Wang Q, Meng F. Dysfunctional Brain Dynamics of Parkinson's Disease and the Effect of Acute Deep Brain Stimulation. Frontiers in Neuroscience. 15: 697909. PMID 34354564 DOI: 10.3389/fnins.2021.697909   
2021 Pagano G, Molloy S, Bain PG, Rabiner EA, Ray Chaudhuri K, Brooks DJ, Pavese N. Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [C]-PHNO PET study. Parkinsonism & Related Disorders. 90: 52-56. PMID 34385007 DOI: 10.1016/j.parkreldis.2021.06.025   
2021 Magnusen AF, Hatton SL, Rani R, Pandey MK. Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease. Frontiers in Neurology. 12: 636139. PMID 34239490 DOI: 10.3389/fneur.2021.636139   
2021 Magnusen AF, Hatton SL, Rani R, Pandey MK. Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease. Frontiers in Neurology. 12: 636139. PMID 34239490 DOI: 10.3389/fneur.2021.636139   
2021 Wang H, Liu Y, Zhao J, Guo X, Hu M, Chen Y. Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review). Clinical Neurology and Neurosurgery. 208: 106844. PMID 34388595 DOI: 10.1016/j.clineuro.2021.106844   
2021 Olubodun-Obadun TG, Ishola IO, Adeyemi OO. Potentials of autophagy enhancing natural products in the treatment of Parkinson disease. Drug Metabolism and Personalized Therapy. PMID 34391219 DOI: 10.1515/dmdi-2021-0128   
2021 Luo B, Lu Y, Qiu C, Dong W, Xue C, Zhang L, Liu W, Zhang W. Altered Spontaneous Neural Activity and Functional Connectivity in Parkinson's Disease With Subthalamic Microlesion. Frontiers in Neuroscience. 15: 699010. PMID 34354566 DOI: 10.3389/fnins.2021.699010   
2021 Lachenmayer ML, Mürset M, Antih N, Debove I, Muellner J, Bompart M, Schlaeppi JA, Nowacki A, You H, Michelis JP, Dransart A, Pollo C, Deuschl G, Krack P. Subthalamic and pallidal deep brain stimulation for Parkinson's disease-meta-analysis of outcomes. Npj Parkinson's Disease. 7: 77. PMID 34489472 DOI: 10.1038/s41531-021-00223-5   
2021 Chung SJ, Lee PH, Sohn YH, Kim YJ. Glucocerebrosidase Mutations and Motor Reserve in Parkinson's Disease. Journal of Parkinson's Disease. PMID 34459414 DOI: 10.3233/JPD-212758   
2021 Jang W, Lee JY, Kim JY, Lee SJ, Kim TY, Choi YY, Kim HT, Kim CK. Intrasubject relationship between striatal 18F-FP-CIT uptake and cardiac 123I-MIBG uptake differs by motor subtype in early Parkinson disease. Medicine. 100: e26995. PMID 34414983 DOI: 10.1097/MD.0000000000026995   
2021 Ishikuro K, Hattori N, Imanishi R, Furuya K, Nakata T, Dougu N, Yamamoto M, Konishi H, Nukui T, Hayashi T, Anada R, Matsuda N, Hirosawa H, Tanaka R, Shibata T, et al. A Parkinson's disease patient displaying increased neuromelanin-sensitive areas in the substantia nigra after rehabilitation with tDCS: a case report. Neurocase. 1-8. PMID 34503372 DOI: 10.1080/13554794.2021.1975768   
2021 Sinha S, Mittal S, Roy R. Parkinson's Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy. Journal of Movement Disorders. PMID 34315206 DOI: 10.14802/jmd.21046   
2021 Sharma A, Müller J, Schuetze K, Rolfes V, Bissinger R, Rosero N, Ahmad A, Franklin BS, Zur B, Fröhlich H, Lang F, Oldenburg J, Pötzsch B, Wüllner U. Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson's Disease. Biology. 10. PMID 34439949 DOI: 10.3390/biology10080716   
2021 Giuliano C, Francavilla M, Ongari G, Petese A, Ghezzi C, Rossini N, Blandini F, Cerri S. Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease. International Journal of Molecular Sciences. 22. PMID 34445626 DOI: 10.3390/ijms22168920   
2021 Zhao Z, Niu Y, Chen P, Zhu Y, Shi L, Zhao X, Wang C, Zhang Y, Gao Z, Jiang W, Ren W, Gu R, Yu Y. Study on the Regulation Effect of Optogenetic Technology on LFP of the Basal Ganglia Nucleus in Rotenone-Treated Rats. Neural Plasticity. 2021: 9938566. PMID 34367273 DOI: 10.1155/2021/9938566   
2021 Zhu G, Wang W, Chen C, Tang L, Liang Y, Zhang Z, Lu Y, Zhao Y. UHPLC-MS-based metabolomics and chemoinformatics study reveals the neuroprotective effect and chemical characteristic in Parkinson's disease mice after oral administration of Wen-Shen-Yang-Gan decoction. Aging. 13. PMID 34339394 DOI: 10.18632/aging.203361   
2021 Luo B, Lu Y, Qiu C, Dong W, Xue C, Liu D, Zhang L, Liu W, Zhang W. Altered Regional Homogeneity and Functional Connectivity during Microlesion Period after Deep Brain Stimulation in Parkinson's Disease. Parkinson's Disease. 2021: 2711365. PMID 34512944 DOI: 10.1155/2021/2711365   
2021 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Molecular Medicine Reports. 24. PMID 34414447 DOI: 10.3892/mmr.2021.12374   
2021 Lin TK, Lin KJ, Lin HY, Lin KL, Lan MY, Wang PW, Wang TJ, Wang FS, Tsai PC, Liou CW, Chuang JH. Glucagon-Like Peptide-1 Receptor Agonist Ameliorates 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Neurotoxicity Through Enhancing Mitophagy Flux and Reducing α-Synuclein and Oxidative Stress. Frontiers in Molecular Neuroscience. 14: 697440. PMID 34305527 DOI: 10.3389/fnmol.2021.697440   
2021 Scheffer DDL, Freitas FC, Aguiar AS, Ward C, Guglielmo LGA, Prediger RD, Cronin SJF, Walz R, Andrews NA, Latini A. Impaired dopamine metabolism is linked to fatigability in mice and fatigue in Parkinson's disease patients. Brain Communications. 3: fcab116. PMID 34423297 DOI: 10.1093/braincomms/fcab116   
2021 Houser MC, Caudle WM, Chang J, Kannarkat GT, Yang Y, Kelly SD, Oliver D, Joers V, Shannon KM, Keshavarzian A, Tansey MG. Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology. Acta Neuropathologica Communications. 9: 139. PMID 34412704 DOI: 10.1186/s40478-021-01240-4   
2021 Conway ZJ, Silburn PA, Perera T, O'Maley K, Cole MH. Low-frequency STN-DBS provides acute gait improvements in Parkinson's disease: a double-blinded randomised cross-over feasibility trial. Journal of Neuroengineering and Rehabilitation. 18: 125. PMID 34376190 DOI: 10.1186/s12984-021-00921-4   
2021 Yemula N, Dietrich C, Dostal V, Hornberger M. Parkinson's Disease and the Gut: Symptoms, Nutrition, and Microbiota. Journal of Parkinson's Disease. PMID 34250955 DOI: 10.3233/JPD-212707   
2021 Zhang C, Lai Y, Li J, He N, Liu Y, Li Y, Li H, Wei H, Yan F, Horn A, Li D, Sun B. Subthalamic and pallidal stimulations in patients with Parkinson's disease: common and dissociable connections. Annals of Neurology. PMID 34390280 DOI: 10.1002/ana.26199   
2021 Ren C, Wang F, He KJ, Zhang YT, Li LX, Zhang JB, Chen J, Mao CJ, Liu CF. Early-life stress induces prodromal features of Parkinsonian with aging in rats. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 34448826 DOI: 10.1093/gerona/glab253   
2021 Moustafa SA, Mohamed S, Dawood A, Azar J, Elmorsy E, Rizk NAM, Salama M. Gut brain axis: an insight into microbiota role in Parkinson's disease. Metabolic Brain Disease. PMID 34370175 DOI: 10.1007/s11011-021-00808-2   
2021 Maillet A, Météreau E, Tremblay L, Favre E, Klinger H, Lhommée E, Le Bars D, Castrioto A, Prange S, Sgambato V, Broussolle E, Krack P, Thobois S. Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34494685 DOI: 10.1002/mds.28722   
2021 Barker RA, Björklund A, Frucht SJ, Svendsen CN. Stem Cell-Derived Dopamine Neurons: Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease? Journal of Parkinson's Disease. 11: 909-917. PMID 34334425 DOI: 10.3233/JPD-219008   
2021 Prasad EM, Hung SY. Current Therapies in Clinical Trials of Parkinson's Disease: A 2021 Update. Pharmaceuticals (Basel, Switzerland). 14. PMID 34451813 DOI: 10.3390/ph14080717   
2021 Zheng C, Zhang F. New Insights into Pathogenesis of L-DOPA-Induced Dyskinesia. Neurotoxicology. PMID 34331976 DOI: 10.1016/j.neuro.2021.07.006   
2021 Kin I, Sasaki T, Yasuhara T, Kameda M, Agari T, Okazaki M, Hosomoto K, Okazaki Y, Yabuno S, Kawauchi S, Kuwahara K, Morimoto J, Kin K, Umakoshi M, Tomita Y, et al. Vagus Nerve Stimulation with Mild Stimulation Intensity Exerts Anti-Inflammatory and Neuroprotective Effects in Parkinson's Disease Model Rats. Biomedicines. 9. PMID 34356853 DOI: 10.3390/biomedicines9070789   
2021 Tozzi A, Sciaccaluga M, Loffredo V, Megaro A, Ledonne A, Cardinale A, Federici M, Bellingacci L, Paciotti S, Ferrari E, La Rocca A, Martini A, Mercuri NB, Gardoni F, Picconi B, et al. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit. Brain : a Journal of Neurology. PMID 34297092 DOI: 10.1093/brain/awab242   
2021 Jaiswal V, Alquraish D, Sarfraz Z, Sarfraz A, Nagpal S, Singh Shrestha P, Mukherjee D, Guntipalli P, Sánchez Velazco DF, Bhatnagar A, Savani S, Halilaj E, Ruxmohan S, Cueva W. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review. Journal of Primary Care & Community Health. 12: 21501327211039709. PMID 34404266 DOI: 10.1177/21501327211039709